Literature DB >> 27174088

Multiple introductions of a reassortant H5N1 avian influenza virus of clade 2.3.2.1c with PB2 gene of H9N2 subtype into Indian poultry.

Chakradhar Tosh1, Shanmugasundaram Nagarajan2, Manoj Kumar2, Harshad V Murugkar2, Govindarajulu Venkatesh2, Shweta Shukla2, Amit Mishra2, Pranav Mishra2, Sonam Agarwal2, Bharati Singh2, Prashant Dubey2, Sushil Tripathi2, Diwakar D Kulkarni2.   

Abstract

Highly pathogenic avian influenza (HPAI) H5N1 viruses are a threat to poultry in Asia, Europe, Africa and North America. Here, we report isolation and characterization of H5N1 viruses isolated from ducks and turkeys in Kerala, Chandigarh and Uttar Pradesh, India between November 2014 and March 2015. Genetic and phylogenetic analyses of haemagglutinin gene identified that the virus belonged to a new clade 2.3.2.1c which has not been detected earlier in Indian poultry. The virus possessed molecular signature for high pathogenicity to chickens, which was corroborated by intravenous pathogenicity index of 2.96. The virus was a reassortant which derives its PB2 gene from H9N2 virus isolated in China during 2007-2013. However, the neuraminidase and internal genes are of H5N1 subtype. Phylogenetic and network analysis revealed that after detection in China in 2013/2014, the virus moved to Europe, West Africa and other Asian countries including India. The analyses further indicated multiple introductions of H5N1 virus in Indian poultry and internal spread in Kerala. One of the outbreaks in ducks in Kerala is linked to the H5N1 virus isolated from wild birds in Dubai suggesting movement of virus probably through migration of wild birds. However, the outbreaks in ducks in Chandigarh and Uttar Pradesh were from an unknown source in Asia which also contributed gene pools to the outbreaks in Europe and West Africa. The widespread incidence of the novel H5N1 HPAI is similar to the spread of clade 2.2 ("Qinghai-like") virus in 2005, and should be monitored to avoid threat to animal and public health.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duck; H5N1 subtype; Highly pathogenic avian influenza; India; Reassortment; Turkey

Mesh:

Substances:

Year:  2016        PMID: 27174088     DOI: 10.1016/j.meegid.2016.05.012

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  10 in total

1.  Redesign and Validation of a Real-Time RT-PCR to Improve Surveillance for Avian Influenza Viruses of the H9 Subtype.

Authors:  Valentina Panzarin; Sabrina Marciano; Andrea Fortin; Irene Brian; Valeria D'Amico; Federica Gobbo; Francesco Bonfante; Elisa Palumbo; Yoshihiro Sakoda; Kien Trung Le; Duc-Huy Chu; Ismaila Shittu; Clement Meseko; Abdoul Malick Haido; Theophilus Odoom; Mame Nahé Diouf; Fidélia Djegui; Mieke Steensels; Calogero Terregino; Isabella Monne
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

2.  Identification of Human Case of Avian Influenza A(H5N1) Infection, India.

Authors:  Varsha Potdar; Megha Brijwal; Rakesh Lodha; Pragya Yadav; Santosh Jadhav; Manohar Lal Choudhary; Aashish Choudhary; Veena Vipat; Nivedita Gupta; Ashok Kumar Deorari; Lalit Dar; Priya Abraham
Journal:  Emerg Infect Dis       Date:  2022-06       Impact factor: 16.126

3.  Novel real-time PCR-based patho- and phylotyping of potentially zoonotic avian influenza A subtype H5 viruses at risk of incursion into Europe in 2017.

Authors:  Mahmoud M Naguib; Annika Graaf; Andrea Fortin; Christine Luttermann; Ulrich Wernery; Nadim Amarin; Hussein A Hussein; Hesham Sultan; Basem Al Adhadh; Mohamed K Hassan; Martin Beer; Isabella Monne; Timm C Harder
Journal:  Euro Surveill       Date:  2017-01-05

4.  Reassortments among Avian Influenza A(H5N1) Viruses Circulating in Indonesia, 2015-2016.

Authors:  Desniwaty Karo-Karo; Rogier Bodewes; Hendra Wibawa; Made Artika; Eko Sugeng Pribadi; D Diyantoro; Widya Pratomo; Agus Sugama; Nani Hendrayani; Iin Indasari; Michael Haryadi Wibowo; David Handojo Muljono; Jan Arend Stegeman; Guus Koch
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883

Review 5.  A Global Perspective on H9N2 Avian Influenza Virus.

Authors:  T Homas P Peacock; Joe James; Joshua E Sealy; Munir Iqbal
Journal:  Viruses       Date:  2019-07-05       Impact factor: 5.048

6.  Selection of an Optimal Recombinant Egyptian H9N2 Avian Influenza Vaccine Strain for Poultry with High Antigenicity and Safety.

Authors:  Se-Hee An; Seung-Eun Son; Jin-Ha Song; Seung-Min Hong; Chung-Young Lee; Nak-Hyung Lee; Young-Ju Jeong; Jun-Gu Choi; Youn-Jeong Lee; Hyun-Mi Kang; Kang-Seuk Choi; Hyuk-Joon Kwon
Journal:  Vaccines (Basel)       Date:  2022-01-21

7.  Highly Pathogenic Avian Influenza A(H5N1) Outbreaks in West Java Indonesia 2015-2016: Clinical Manifestation and Associated Risk Factors.

Authors:  Desniwaty Karo-Karo; Eko Sugeng Pribadi; Fransiscus Xaverius Sudirman; Sussi Widi Kurniasih; Iin Indasari; David Handojo Muljono; Guus Koch; Jan Arend Stegeman
Journal:  Microorganisms       Date:  2019-09-06

8.  Knowledge and remaining gaps on the role of animal and human movements in the poultry production and trade networks in the global spread of avian influenza viruses - A scoping review.

Authors:  Claire Hautefeuille; Gwenaëlle Dauphin; Marisa Peyre
Journal:  PLoS One       Date:  2020-03-20       Impact factor: 3.240

9.  The Pattern of Highly Pathogenic Avian Influenza H5N1 Outbreaks in South Asia.

Authors:  Sukanta Chowdhury; Mohammad Enayet Hossain; Probir Kumar Ghosh; Sumon Ghosh; Muhammad Belal Hossain; Cindy Beard; Mahmudur Rahman; Mohammed Ziaur Rahman
Journal:  Trop Med Infect Dis       Date:  2019-11-27

10.  Inhibitory Potentiality of Secondary Metabolites Extracted from Marine Fungus Target on Avian Influenza Virus-A Subtype H5N8 (Neuraminidase) and H5N1 (Nucleoprotein): A Rational Virtual Screening.

Authors:  Md Mukthar Mia; Mahamudul Hasan; Muhammad Milon Miah; Mohammad Abdus Shahid Hossain; Senior Executive Veterinary Technical Services Md Shariful Islam; Veterinary Consultant Public Health Rifat Noor Shanta
Journal:  Vet Anim Sci       Date:  2022-01-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.